Table 2.
Univariable Cox regression model analyses of OS for nomogram.
| Characteristics | OR | Univariable analysis | p value | |
|---|---|---|---|---|
| 95% CI lower | 95% CI upper | |||
| AGE | ||||
| ≤65y | reference | |||
| >65y | 1.308 | 0.884 | 1.934 | 0.181 |
| DFAC | ||||
| 0 | reference | |||
| 1 | 0.640 | 0.390 | 1.050 | 0.079 |
| 2 | 0.657 | 0.286 | 1.510 | 0.325 |
| Child-Pugh | ||||
| A | reference | |||
| B | 1.473 | 0.905 | 2.397 | 0.121 |
| C | 2.539 | 0.080 | 4.228 | 0.593 |
| CV | ||||
| <50 | reference | |||
| 50-100 | <0.001 | <0.0001 | <0.0001 | 0.953 |
| >100 | 0.650 | 0.433 | 0.976 | 0.038** |
| NHG | ||||
| 1 | reference | |||
| 2 | 1.220 | 0.650 | 2.288 | 0.538 |
| 3 | 1.224 | 0.640 | 2.342 | 0.544 |
| 4 | 1.350 | 0.434 | 4.197 | 0.606 |
| PLT | ||||
| <100 | reference | |||
| 100-300 | 1.405 | 0.809 | 2.439 | 0.229 |
| >300 | 1.459 | 0.631 | 3.374 | 0.379 |
| VASTP | ||||
| None | reference | |||
| Micro | 0.879 | 0.538 | 1.436 | 0.608 |
| Macro | 1.933 | 0.886 | 4.216 | 0.099 |
| P-STAGE | ||||
| 1 | reference | |||
| 2 | 1.080 | 0.636 | 1.835 | 0.777 |
| 3 | 2.318 | 1.499 | 3.585 | <0.001** |
| 4 | 7.824 | 1.884 | 32.502 | 0.005** |
| BMI | ||||
| <18.5 | reference | |||
| 18.5-23.9 | 0.976 | 0.654 | 1.458 | 0.906 |
| >23.9 | 0.555 | 0.272 | 1.129 | 0.106 |
| RT | ||||
| R0 | reference | |||
| R1 | 0.969 | 0.308 | 3.048 | 0.957 |
| R2 | 2.791 | 1.211 | 6.430 | 0.017** |
| VHS | ||||
| None | reference | |||
| HBV | 0.607 | 0.367 | 1.004 | 0.053 |
| HCV | 1.205 | 0.578 | 2.515 | 0.620 |
| HBV+HCV | 1.873 | 1.107 | 3.169 | 0.020** |
| CFDR | ||||
| None | reference | |||
| Yes | 1.339 | 0.896 | 2.000 | 0.157 |
| ALB | ||||
| <3.5g/dl | reference | |||
| >3.5g/dl | 1.435 | 0.725 | 2.840 | 0.303 |
| TB | ||||
| <1.4mg/dl | reference | |||
| >1.4mg/dl | 1.066 | 0.435 | 2.613 | 0.889 |
| AFP | ||||
| ≤25 | reference | |||
| 25-400 | 1.289 | 0.724 | 2.293 | 0.391 |
| >400 | 3.646 | 2.485 | 5.351 | <0.001** |
| THCR | ||||
| None | reference | |||
| Yes | 0.919 | 0.478 | 1.768 | 0.802 |
| PTS | ||||
| None | reference | |||
| Yes | 2.129 | 1.436 | 3.158 | <0.001** |
| POT | ||||
| None | reference | |||
| Yes | 1.180 | 0.701 | 1.988 | 0.535 |
| RFCH | ||||
| None | reference | |||
| Yes | 1.351 | 0.907 | 2.014 | 0.141 |
| Gender | ||||
| Female | reference | |||
| Male | 1.044 | 0.695 | 1.569 | 0.838 |
| OM | ||||
| None | reference | |||
| Yes | 1.279 | 0.861 | 1.898 | 0.225 |
| TNM | ||||
| I | reference | |||
| II | 2.200 | 1.374 | 3.521 | 0.001** |
| III | 2.871 | 1.761 | 4.682 | <0.001** |
| IV | 3.237 | 1.272 | 8.238 | 0.014** |
OR, Odds ratio; CI, confidence interval; **, It is statistically significant and included in the multivariate COX regression analysis. DFAC, degree of inflammation adjacent to the cancer; Child-Pugh, Child pneumonia classification grade; CV, creatinine value; NHG, tumor histology grade; PLT, platelet count; VASTP, vascular tumor cell type; P.STAGE, pathological stage; BMI, body mass index; RT, resection marginal residual tumor; VHS, viral hepatitis serology; CFDR, first-degree relative hepatocellular carcinoma; ALB, albumin; TB, total bilirubin; AFP, alpha-fetoprotein; THCR, risk factors; PTS, patients Tumor status; POT, postoperative treatment; RFCH, relative family cancer history; OM, other malignant tumors, TNM, tumor node metastasis.